Subscribe Us

header ads

Recents

header ads

Life Sciences BPO Market Size At Around US$ 835.2 Bn In 2030

The life sciences BPO market would grow at a CAGR of 9.26% over the predicted time frame. The market is expected to increase in value from US$ 411.16 Bn in 2022 to US$ 835.2Bn in 2030.

Life Sciences BPO Market Size 2022 To 2030

The on life sciences BPO Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2072

Report Scope of the Life Sciences BPO Market

Report CoverageDetails
Market Size in 2022

USD 411.16 Billion

Market Size by 2030

USD 835.2 Billion

Growth Rate from 2022 to 2030CAGR of 9.26%
Base Year2021
Forecast Period2022 to 2030
Segments CoveredServices, Application, Protocol and Geography

A recent report provides crucial insights along with application based and forecast information in the Global Life sciences BPO Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Life sciences BPO market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Life sciences BPO market are included as given below:

Life sciences BPO Market Key Players

  • International Business Machines Corp
  • IOVIA
  • PAREXEL International Corp
  • Lonza Group
  • Infosys.Ltd
  • ICON plc
  • Genpact LTD
  • Covance, Inc. (Labcorp)
  • Catalent, Inc
  • Boehringer Ingelheim Gmbh
  • Atos SE
  • Accenture plc
  • Syneos Health, Inc
  • Charkes River Laboratories International, Inc
  • Wuxi AppTec Co, Ltd
  • Medpace Holdings, Inc
  • PRA Health Sciences, Inc
  • Cognizant Technology Solutions
  • Quintiles Transactional Corporation
  • ProMab Biotechnologies, Inc
  • Boehringer Ingelheim Gmbh

Market Segments

By Services 

  • Pharmaceutical Outsourcing
    • Contract Manufacturing Market
      • API
      • Finished Dose Form
      • Packaging
    • Contract Research Organizations
      • Drug Discovery
      • Pre-clinical Studies
      • Clinical Trial Studies
      • Regulatory Services
      • Pharmacovigilance
  • Medical devices outsourcing
    • Contract Manufacturing Market
      • Electronic Manufacturing Services
      • Finished Goods
      • Raw Materials/ Components
    • Contract Research Organizations
      • Regulatory Consulting Services
      • Product Design and Development Services
      • Product Testing Services
      • Product Implementation Services
      • Product Upgrade Services
      • Product Maintenance Services
  • Contract sales and marketing outsourcing
  • Others

By Application

  • Pharmaceuticals
  • Medical Device applications
  • Biopharmaceuticals
  • Research and development
  • others

By Protocol

  • Development
  • Site Management

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Report Objectives

  • To define, describe, and forecast the global life sciences BPO market based on product, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
  • To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
  • To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the life sciences BPO market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Life Sciences BPO Market 

5.1. COVID-19 Landscape: Life Sciences BPO Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Life Sciences BPO Market, By Services

8.1. Life Sciences BPO Market, by Services, 2022-2030

8.1.1 Pharmaceutical Outsourcing

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Medical devices outsourcing

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Contract sales and marketing outsourcing

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Life Sciences BPO Market, By Application

9.1. Life Sciences BPO Market, by Application, 2022-2030

9.1.1. Pharmaceuticals

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Medical Device applications

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Biopharmaceuticals

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Research and development

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. others

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Life Sciences BPO Market, By Protocol 

10.1. Life Sciences BPO Market, by Protocol, 2022-2030

10.1.1. Development

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Site Management

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Life Sciences BPO Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Services (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Services (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Services (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Services (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Services (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Protocol (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Services (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Protocol (2017-2030)

Chapter 12. Company Profiles

12.1. International Business Machines Corp

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. IOVIA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. PAREXEL International Corp

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Lonza Group

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Infosys.Ltd

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. ICON plc

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Genpact LTD

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Covance, Inc. (Labcorp)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Catalent, Inc

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Boehringer Ingelheim Gmbh

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Post a Comment

0 Comments